{"title":"【子宫内膜增生患者的合并症】。","authors":"S A Fetesku","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The aim was to evaluate the prevalence of concomitant somatic pathology in patients with endometrial hyperplasia. It is shown that the incidence of endometrial hyperplastic processes of combination and somatic pathology is 50%. The main types of comorbid diseases are obesity, metabolic syndrome, gastrointestinal and cardiovascular disorders.</p>","PeriodicalId":18100,"journal":{"name":"Likars'ka sprava","volume":" ","pages":"157-9"},"PeriodicalIF":0.0000,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[COMORBIDITIES IN PATIENTS WITH ENDOMETRIAL HYPERPLASIA].\",\"authors\":\"S A Fetesku\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The aim was to evaluate the prevalence of concomitant somatic pathology in patients with endometrial hyperplasia. It is shown that the incidence of endometrial hyperplastic processes of combination and somatic pathology is 50%. The main types of comorbid diseases are obesity, metabolic syndrome, gastrointestinal and cardiovascular disorders.</p>\",\"PeriodicalId\":18100,\"journal\":{\"name\":\"Likars'ka sprava\",\"volume\":\" \",\"pages\":\"157-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Likars'ka sprava\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Likars'ka sprava","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[COMORBIDITIES IN PATIENTS WITH ENDOMETRIAL HYPERPLASIA].
The aim was to evaluate the prevalence of concomitant somatic pathology in patients with endometrial hyperplasia. It is shown that the incidence of endometrial hyperplastic processes of combination and somatic pathology is 50%. The main types of comorbid diseases are obesity, metabolic syndrome, gastrointestinal and cardiovascular disorders.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
